April 9, 2025 | Timely Disclosure Information | StemRIM Announces Setting the Record Date for Extraordinary General Meeting of Shareholders Convening and Holding of Extraordinary General Meeting of Shareholders, and Reduction of Capital Stock (Capital Decrease) |
---|---|---|
April 3, 2025 | Timely Disclosure Information | StemRIM Announces Patent Registration (China) for the Use of the HMGB1 Fragment Peptide, Redasemtide, as an Additional Therapeutic Indication of Traumatic articular Cartilage Deficiency Syndrome, Osteoarthritis, and Osteochondritis dissecans |
April 2, 2025 | Timely Disclosure Information | StemRIM Announces the Interim Analysis Results for the Global Phase 2b Clinical Trial in Patients with Acute Ischemic Stroke |
March 17, 2025 | Presentation Materials | Presentation Materials for Six Months Ended January 31 2025 |
Stock Information
Investor Library
Firm | Analyst |
---|---|
Nomura Securities Co., Ltd. | Mr. Maeda Kouta |
Nomura Securities Co., Ltd. | Mr. Hiroyuki Matsubara |
Marusan Securities Co., Ltd. | Mr. Tsuyoshi Ono |